Skip to main content
SpringerLink
Log in
Book cover

Prostatakarzinom — urologische und strahlentherapeutische Aspekte pp 136–156Cite as

Klinischer Einsatz und therapeutische Ergebnisse der 3D-geplanten Konformationstherapie des Prostatakarzinoms

  • Chapter

  • 35 Accesses

Zusammenfassung

Das Prostatakarzinom stellt eine Hauptindikation bei der Entwicklung 3D-konformer Bestrahlungsverfahren dar. Dabei wird das Zielvolumen in einem dreidimensionalen Patientenmodell definiert und dieses durch einen Bestrahlungsplan mit hoher Konformität bei gleichzeitig steilen Dosisgradienten zu kritischen Risikoorganen erfaßt. Ziel ist eine bessere lokale Kontrolle bei gleichzeitig niedrigeren Nebenwirkungsraten der Strahlenbehandlung und möglicherweise damit auch eine Verbesserung der Über-lebensrate der Patienten. Mit der Möglichkeit der individuellen Anpassung der Dosisverteilung an das zu bestrahlende Zielvolumen bekommen allerdings Aspekte wie Lagerungsgenauigkeit, Organbewegung und Verifikation der Bestrahlungstechnik besondere Bedeutung.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Akazawa PF, Roach M 3rd, Picket B et al. (1996) Three dimensional comparison of blocked arcs vs. four and six field conformal treatment of the prostate. Radiother Oncol 41: 83–86.

    PubMed  CAS  Google Scholar 

  2. Bagshaw MA, Cox RS, Ray, GR (1988) Status of radiation treatment of prostatic cancer at Stanford University. NCI Monograph7: 47–60.

    Google Scholar 

  3. Bagshaw MA, Kaplan ID, Cox RC (1993) Radiation therapy for localized disease. Cancer (Suppl) 71/3.

    Google Scholar 

  4. Baiter-JM, Sandler-HM, Lam-K et al. (1995) Measurement of prostate movement over the course of routine radiotherapy using implanted markers. Int J Radiat Oncol Biol Phys 31/1:113–118.

    Article  PubMed  Google Scholar 

  5. Balter-JM, Lam-KL, Sandler-HM et al. (1995) Automated localization of the prostate at the time of treatment using implanted radiopaque markers: technical feasibility. Int J Radiat Oncol Biol Phys 33/5:1281–1286.

    Article  PubMed  Google Scholar 

  6. Benk VA, Adams JA, Shipley WU et al. (1993) Late rectal bleeding following combined X-ray and proton high dose irradiation for patients with stages T3–T4 prostate carcinoma. Int J Radiat Oncol Biol Phys 26: 551–557.

    Article  PubMed  CAS  Google Scholar 

  7. Bijhold J, Lebesque JV, Hart AAM et al. (1992) Maximizing setup accuracy using portal images as applied to a conformal boost technique for prostate cancer. Radiother Oncol 24: 261–271.

    Article  PubMed  CAS  Google Scholar 

  8. Catalona WJ, Stein AJ (1982) Staging errors in clinically localized prostate cancer. J Urol 127: 452–456.

    PubMed  CAS  Google Scholar 

  9. Catalona WJ, Fleischmann J, Menon M (1983) Pelvic lymph node status as a predictor of extracapsular tumor extension of clinical stage B prostate cancer. J Urol 129: 327–329.

    PubMed  CAS  Google Scholar 

  10. Corn BW, Hanks GE, Schultheiss TE et al. (1995) Conformal treatment of prostate cancer with improved targeting: Superior prostate specific antigen response compared to standard treatment. Int J Radiat Oncol Biol Phys 32: 325–330.

    Article  PubMed  CAS  Google Scholar 

  11. Cox JA, Zagoria RJ, Raben M (1994) Prostate cancer: comparison of retrograde urethrography and computed tomography in radiotherapy planning. Int J Radiat Oncol Biol Phys 29:1119–1123.

    Article  PubMed  CAS  Google Scholar 

  12. Crook JM, Raymond Y, Salhani D, Yang-H, Esche B (1995) Prostate motion during standard radiotherapy as assessed by fiducial markers. Radiother Oncol 37/1: 35–42.

    Article  PubMed  CAS  Google Scholar 

  13. Chelsky MJ, Schnall MD, Seidmon EJ, Pollack HM (1993) Use of endorectal surface coil magnetic resonance imaging for local staging of prostate cancer. J Urol 150(2 Pt 1): 391–395.

    PubMed  CAS  Google Scholar 

  14. Diaz A, Roach M 3rd, Marquez C et al. (1994) Indications for and the significance of seminal vesicle irradiation during 3D conformal radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 30/2: 323–329.

    PubMed  CAS  Google Scholar 

  15. Dickens CW (1981) Personalized fixation using a vacuum consolidation technique. Br J Radiol 54: 257–258.

    Article  PubMed  CAS  Google Scholar 

  16. El Gayed AAH, Bel A, Vijlbrief R, Bartelink H, Lebesque JV (1993) Time trend of patient setup deviations during pelvic irradiation using electronic portal imaging. Radiother Oncol 26:162–174.

    Article  PubMed  CAS  Google Scholar 

  17. Ennis RD, Flynn SD, Fischer DB, Peschel RE (1994) Preoperative serum prostate-specific antigen and Gleason grade as predictors of pathologic stage in clinically organ confined prostate cancer: implications for the choice of primary treatment. Int J Radiat Oncol Biol Phys 30/2: 317–22.

    PubMed  CAS  Google Scholar 

  18. Epstein B, Peter R, Martin E, Hunt M, Hanks GE (1992) Low complication rate with conformal radiotherapy for cancer of the prostate. Radiother Oncol 24: 394.

    Google Scholar 

  19. Epstein BE, Hanks GE (1993) Radiation therapy techniques and dose selection in the treatment of prostate cancer. Semin Radiat Oncol 3:179–186.

    Article  PubMed  Google Scholar 

  20. Forman JD, Duclos M, Shamsa F, Porter AT, Orton C (1996) Hyperfractionated conformal radiotherapy in locally advanced prostate cancer: results of a dose escalation study. Int J Radiat Oncol Biol Phys 34/3: 655–662.

    Article  PubMed  CAS  Google Scholar 

  21. Fukunaga-Johnson N, Sandler HM, McLaughlin PW et al. (1997) Results of 3D conformal radiotherapy in the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys 38: 311–317.

    Article  PubMed  CAS  Google Scholar 

  22. Graham SD Jr, Napalkov P, Watts L, Salomao D, Bostwick DG (1996) Microvascular invasion of the seminal vesicles in adenocarcinoma of the prostate. Prostate28/6: 359–363.

    Article  CAS  Google Scholar 

  23. Hanley JA, Lumley MA, Mageras GS et al. (1997) Measurement of patient positioning errors in three-dimensional conformal radiotherapy of the prostate. Int J Radiat Oncol Biol Phys 37: 435–444.

    Article  PubMed  CAS  Google Scholar 

  24. Hanks GE, Schultheiss TE, Hunt M, Epstein B (1995) Factors influencing incidence of acute grade 2 morbidity in conformal and standard radiation treatment of prostate cancer. Int J Radiat Oncol Biol Phys 31: 25–29.

    Article  PubMed  CAS  Google Scholar 

  25. Hanks GE, Schultheiss TE, Hanlon AL et al. (1997) Optimization of conformal radiation treatment of prostate cancer: report of a dose escalation study.Int J Radiat Oncol Biol Phys 37: 543–550.

    Article  PubMed  CAS  Google Scholar 

  26. Hanlon AL, Schultheiss TE, Hunt MA et al. (1997) Chronic rectal bleeding after high dose conformal treatment of prostate cancer warrants modification of existing morbidity scales. Int J Radiat Oncol Biol Phys 38: 59–63.

    Article  PubMed  CAS  Google Scholar 

  27. Herk M van, Bruce A, Kroes AP, Shouman T, Touw A, Lebesque JV (1995) Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional image registration. Int J Radiat Oncol Biol Phys 33/5:1311–1320.

    Article  PubMed  Google Scholar 

  28. Huguenin P, Glanzmann C, Lütolf UM (1995) Kleinvolumige Bestrahlung lokalisierter Prostata-Karzinome: wie klein ist groß genug? Strahlenther Onkol 171: 679–684.

    PubMed  CAS  Google Scholar 

  29. Kabalin JN, Hodge KK, McNeal JE, Freiha FS, Stamey TA (1989) Identification of residual cancer in the prostate following radiation therapy: role of transrectal ultrasound guided biopsy and prostate specific antigen. J Urol 142(2 Pt 1): 326–331.

    PubMed  CAS  Google Scholar 

  30. Leibel SA, Heimann R, Kutcher GJ et al. (1994) Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: Preliminary results of a phase I dose-escalation study. Int J Radiat Oncol Biol Phys 28: 55–65.

    Article  PubMed  CAS  Google Scholar 

  31. Lawton CA, Won M, Pilepich MV et al. (1991) Longterm treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: Analysis of RTOG studies 75–06 and 77–06. Int J Radiat Oncol Biol Phys 21: 935–939.

    Article  PubMed  CAS  Google Scholar 

  32. Lee M, Wynne C, Webb S, Nahum AE, Dearnaley D (1994) A comparison of proton and megavoltage X-ray treatment planning for prostate cancer. Radiother Oncol 33: 239–253.

    Article  PubMed  CAS  Google Scholar 

  33. Lee WR, Hank GE, Hanlon AL, Schultheiss TE, Hunt MA (1996) Lateral rectal shielding reduces late rectal morbidity following high-dose 3-D-conformal radiation therapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 35/2: 251–257

    Article  PubMed  CAS  Google Scholar 

  34. Ling CC, Burman C, Chen SC et al. 1996) Conformal radiation treatment of prostate cancer using inverselley-planned intensity-modulated photon beams produced with dynamic multileaf collimation. Int J Radiat Oncol Biol Phys 35: 721–730.

    Article  PubMed  CAS  Google Scholar 

  35. Marks LB, Anscher MS (1992) Radiotherapy for prostate cancer: should the seminal vesicles be considered target. Int J Radiat Oncol Biol Phys 24: 435–440.

    Article  PubMed  CAS  Google Scholar 

  36. Mukamel (1987) The incidence and significance of seminal vesicle invasion in patients with adenocarcinoma of the prostate. Cancer 59:1535–1538.

    Article  PubMed  CAS  Google Scholar 

  37. Neal AJ, Oldham M, Dearnaley DP (1995) Comparison of treatment techniques for conformal radiotherapy of the prostate using dose-volume histograms and normal tissue complication probabilities. Radiother Oncol 37: 29–34.

    Article  PubMed  CAS  Google Scholar 

  38. Oesterling JE, Brendler CB, Epstein JI, Kimball AWJ, Walsh PC (1987) Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate. J Urol 138: 92–98.

    PubMed  CAS  Google Scholar 

  39. Partin AW, Yoo J, Carter HB et al. (1993) The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 150/1: 110–114.

    PubMed  CAS  Google Scholar 

  40. Pickett B, Roach M, Horine P, Verhey L, Phillips TL (1994) Optimization of the oblique angles in the treatment of prostate cancer during six-field conformal radiotherapy. Med Dosim 19: 237–254.

    PubMed  CAS  Google Scholar 

  41. Roach M III., Pickett B, Holland J et al. (1993) The role of urethrogram during simulation for localized prostate cancer. Int J Radiat Oncol Biol Phys 25: 299–397.

    Article  PubMed  Google Scholar 

  42. Rosenthal SA, Roach M, Goldsmith BJ et al. (1993) Immobilization improves the reproducibiliy of patient positioning during six-field conformal radiation therapy for prostate carcinoma. Int J Radiat Oncol Biol Phys 27: 921–926.

    Article  PubMed  CAS  Google Scholar 

  43. Rudat V, Flentje M, Oetzel D et al. (1994) Influence of the positioning error on 3D conformal dose distribution during fractionated radiotherapy. Radiother Oncol 33: 56–63.

    Article  PubMed  CAS  Google Scholar 

  44. Rudat V, Schraube P, Oetzel D et al. (1996) Combined error of patient positioning variability and prostate motion uncertainty in 3D conformal radiotherapy of localized prostate cancer. Int J Radiat Oncol Biol Phys 35/5:1027–1034.

    Article  PubMed  CAS  Google Scholar 

  45. Sandler HM, McLaughlin PW, Ten Haken RK et al. (1995) Three dimensional conformal radiotherapy for the treatment of prostate cancer: low risk of chronic rectal morbidity observed in a large series of patients. Int J Radiat Oncol Biol Phys 33: 797–801.

    Article  PubMed  CAS  Google Scholar 

  46. Sandler HM, McLaughlin PW, Kish KE, Lichter AS (1995) Results of 3D conformal radiotherapy in the treatment of 707 patients with localized prostate cancer. Proc. Astro: Int J Radiat Oncol Biol Phys 32 (S1): 141.

    Article  Google Scholar 

  47. Sailer SL, Rosenman JG, Symon JR, Cullip TJ, Chaney EL (1994) The tetrad and hexad: maximum beam separation as a starting point for noncoplanar 3D treatment planning: prostate cancer as a test case. Int J Radiat Oncol Biol Phys 30: 439–446.

    PubMed  CAS  Google Scholar 

  48. Schild SE, Buskirk SJ, Robinow JS (1991) Prostate cancer: Retrograde urethrography to improve treatment planning for radiation therapy. Radiology 181: 885–887.

    PubMed  CAS  Google Scholar 

  49. Schultheiss TE, Lee WR, Hunt MA et al. (1997) Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 37: 3–11.

    Article  PubMed  CAS  Google Scholar 

  50. Sharma R, Warmelink C, Yudelev M et al. (1995) Description of a 3D conformal neutron and photon radiotherapy technique for prostate cancer. Med Dosim 20: 45–53.

    Article  PubMed  CAS  Google Scholar 

  51. Shipley WU, Verhey LJ, Munzenrider JE et al. (1995) Advanced prostate cancer: The results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int J Radiat Oncol Biol Phys 32/1: 3–12.

    Article  PubMed  CAS  Google Scholar 

  52. Soffen EM, Hanks GE, Hwang CC et al. (1991) Conformal static field therapy for low volume low grade prostate cancer with rigid immobilization. Int J Radiat Oncol Biol Phys 20:141–146.

    Article  PubMed  CAS  Google Scholar 

  53. Soffen EM, Hanks GE, Hunt M, Epstein BE (1992) Conformal static field radiation therapy treatment of early prostate cancer vs. non-conformal techniques: a reduction in acute morbidity. Int J Radiat Oncol Biol Phys 24: 485–488.

    Article  PubMed  CAS  Google Scholar 

  54. Smit WGJM, Helle PA, Putten WLJ van et al. (1990) Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose. Int J Radiat Oncol Biol Phys 18: 23–29.

    Article  PubMed  CAS  Google Scholar 

  55. Tait DM, Nahum AE, Meyer LC et al. (1997) Acute toxicity in pelvic radiotherapy: a randomized trial of conformal vs. conventional treatment. Radiother Oncol 42:121–136.

    Article  PubMed  CAS  Google Scholar 

  56. Ten Haken RK, Perez Tamayo C, Tesser RJ et al. (1989) Boost treatment of the prostate using shaped fixed fields. Int J Radiat Oncol Biol Phys 16:193–200.

    Article  PubMed  Google Scholar 

  57. Ten Haken RK, Forman JD, Heimburger DK et al. (1991) Treatment planning issues related to prostate movement in response to differential filling of the rectum and bladder. Int J Radiat Oncol Biol Phys 20/6:1317–1324.

    Article  PubMed  Google Scholar 

  58. Vigneault E, Pouliot J, Laverdiere J, Roy J, Dorion M (1997) Electronic portal imaging device detection of radioopaque markers for the evaluation of prostate position during megavoltage irradiation: a clinical study. Int J Radiat Oncol Biol Phys 37/1: 205–212.

    Article  PubMed  CAS  Google Scholar 

  59. Vijayakumar S, Awan A, Karrison T et al. (1993) Acute toxicity during external beam radiotherapy for localized prostate cancer: comparison odf different techniques. Int J Radiat Oncol Biol Phys 25: 359–371.

    Article  PubMed  CAS  Google Scholar 

  60. Vijverberg PL, Giessen MC, Kurth-KH et al. (1992) Is preoperative transrectal ultrasonography of value in localised prostatic carcinoma? A blind comparative study between preoperative transrectal ultrasonography and the histopathological radical prostatectomy specimen. Eur J Surg Oncol 18/5: 449–455.

    PubMed  CAS  Google Scholar 

  61. Villers AA, McNeal JE, Redwine EA et al. (1989) The role of perineural space invasion in the local spread of prostatic adenocarcionoma. J Urol 142: 763–768.

    PubMed  CAS  Google Scholar 

  62. Villers AA, McNeal JE, Redwine EA, Freiha FS, Stamey TA (1990) Pathogenesis and biological significance of seminal vesicle invasion in prostatic adenocarcinoma. J Urol 143:1183–1187.

    PubMed  CAS  Google Scholar 

  63. Zelefsky MJ, Happersettt, MA, Leibel SA et al. (1997) The effect of treatment positioning on normal tissue dose in patients with prostate cancer treated with 3-D-conformal radiotherapy. Int J Radiat Oncol Biol Phys 37:13–19.

    Article  PubMed  CAS  Google Scholar 

  64. Zierhut D, Flentje M, Sroka-Perez G, Rudat V (1997) EngenhartCabillic, Wannemacher, M. Konformierende Strahlentherapie des lokalisierten Prostatakarzinoms: akute Toleranz und frühe Wirksamkeit. Strahlenther Onkol 173: 98–105.

    CAS  Google Scholar 

Download references

Authors
  1. J. Willner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Flentje
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Willner, J., Flentje, M. (1999). Klinischer Einsatz und therapeutische Ergebnisse der 3D-geplanten Konformationstherapie des Prostatakarzinoms. In: Prostatakarzinom — urologische und strahlentherapeutische Aspekte. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60064-7_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60064-7_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64241-8

  • Online ISBN: 978-3-642-60064-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation